CRVS - Corvus Pharmaceuticals GAAP EPS of -$0.17 misses by $0.01 May, 08 2023 04:28 PM Corvus Pharmaceuticals Inc. 2023-05-08 16:28:06 ET Corvus Pharmaceuticals press release ( NASDAQ: CRVS ): Q1 GAAP EPS of -$0.17 misses by $0.01 . For further details see: Corvus Pharmaceuticals GAAP EPS of -$0.17 misses by $0.01